IP Library Granted Patent US 8,663,659
Granted Patent B2
US 8,663,659 · App. 12/529,659 · Granted Mar 4, 2014

Orally administrable films

Inventors: Stephan Meyer (Genève, CH); Greg Slominski (Elmwood, NE); Christopher Edward Fankhauser (Eagle, NE)
Assignee: Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,663,659
App. No.
12/529,659
Granted
Mar 4, 2014
Kind
B2
Abstract

The invention relates to oral disintegrable films, which are mucoadhesive, which completely disintegrate in the mouth of a consumer within 1 to 10 minutes, and which include an alkaline substance and optionally a pharmaceutically active substance.

Claims (22)

1. An oral disintegrable film comprising a layer, which layer comprises

(a) a film-forming agent,

(b) croscarmellose sodium or a mixture of croscarmellose sodium and corn starch; and

(c) an alkaline substance.

2. The oral disintegrable film according to claim 1 , which film in addition comprises a pharmaceutically active substance.

3. The oral disintegrable film according to claim 2 , wherein the pharmaceutically active substance is prone to chemically react with the alkaline substance and the pharmaceutically active substance is separated from the alkaline substance thereby avoiding any premature chemical reaction before oral application.

4. The oral disintegrable film according to claim 1 , wherein the film-forming agent is selected from the group consisting of cellulose, cellulose ether derivatives, polyalkylene oxides, polyalkylene glycols, polyalkylene glycol copolymers, acrylic acid polymers, acrylic acid copolymers, methacrylic acid polymers, methacrylic acid copolymers, polyacrylamides, pullulan, polyvinyl pyrrolidone, polyvinyl alcohol, polyvinyl alcohol copolymers, carboxyvinyl polymers, modified starch, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein, synthetically or naturally occurring gums, carrageanan, alginic acid, salts of alginic acid, and any mixture thereof.

5. The oral disintegrable film according to claim 1 , wherein the alkaline substance is selected from the group consisting of sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, and any mixture thereof.

6. The oral disintegrable film according to claim 2 , wherein the pharmaceutically active substance is a nicotine active.

7. The oral disintegrable film according to claim 1 wherein the film-forming agent is

a water-soluble film-forming polymer and

0.1-20% by weight of the film of a hydrocolloid/biopolymer gum.

8. The oral disintegrable film according to claim 7 , which film comprises 0.3 to 5% by weight of the hydrocolloid/biopolymer gum (a2).

9. The oral disintegrable film according to claim 1 , wherein the film adheres to the buccal mucosa.

10. The oral disintegrable film according to claim 1 , wherein the film completely disintegrates in the mouth within 1 to 10 minutes.

11. The oral disintegrable film according to claim 1 , wherein the film has a thickness of 5 to 250 micrometers.

12. The oral disintegrable film according to claim 7 , wherein the pharmaceutically active substance is a nicotine active.

13. The oral disintegrable film of claim 12 , wherein the nicotine active is a nicotine salt.

14. The oral disintegrable film of claim 13 , wherein the nicotine salt is nicotine bitartrate.

15. The oral disintegrable film according to claim 7 , wherein the water-soluble film-forming polymer is hydroxypropylmethyl cellulose.

16. The oral disintegrable film according to claim 7 , wherein the hydrocolloid/biopolymer gum is selected from the group consisting of carrageanan, alginic acid, salts of alginic acid, and mixtures thereof.

17. The oral disintegrable film according to claim 7 , wherein the hydrocolloid/biopolymer gum is xanthan gum.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2020
From: NOVARTIS AG
To: GSK CONSUMER HEALTHCARE S.A.
Reel/Frame 051658/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2009
From: MEYER, STEPHAN; SLOMINSKI, GREG; FANKHAUSER, CHRISTOPHER EDWARD
To: NOVARTIS AG
Reel/Frame 023221/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2009
From: MEYER, STEPHAN; SLOMINSKI, GREG; FANKHAUSER, CHRISTOPHER EDWARD
To: NOVARTIS AG
Reel/Frame 023184/0738 →
Continuity (2)
Provisional Application 60893419 · Mar 7, 2007
Related Publication 20100063110A1 · Mar 11, 2010